Intrinsiqq
M1 Kliniken AG logo

M1 Kliniken AG Quality Score

M12.XETR

⊜ Compare
Quality91

Strong across all measured dimensions. No single area is pulling the score down meaningfully.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
90/100
15.8x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
100/100
9.8x

Under 20x cash flow, well covered

Revenue Growth
70/100
8.5%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
100/100
25.8%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
80/100
0.0%

Roughly flat, no meaningful dilution

Margin Trend
100/100
+7.0pp

Expanded 3+pp, strong improvement

Capital Structure
100/100
-€40M

Net cash position, no leverage concern

2022
€52.0M
€14.0M
2023
€26.0M
€11.0M
2024
€24.0M
€10.0M
2025
€47.0M
€7.00M
CashDebt
Return on Capital
80/100
17.2%

15–20%, well above cost of capital

Customize WeightsPremiumUpgrade

M1 Kliniken (M12.XETR) quality: score, margins and returns

M1 Kliniken (M12.XETR) scores 91/100 on Intrinsiqq's quality score (a high-quality business), a weighted blend of 8 metrics each scored 0 to 100, on 10.1% operating margins and 17.2% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is M1 Kliniken (M12.XETR) a high-quality business?+

M1 Kliniken scores 91 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a high-quality business on these measures. Recent figures include a 10.1% operating margin and a 17.2% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does M1 Kliniken's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from M12.XETR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where M1 Kliniken scores well and where it falls behind.

What is M1 Kliniken's return on invested capital (ROIC)?+

M1 Kliniken earns about 17.2% on its invested capital, which is strong. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to M12.XETR's margins and growth on this scorecard to judge durability.

How profitable is M1 Kliniken?+

M1 Kliniken runs an operating margin of about 10.1% and a net margin of about 6.6%. Revenue has grown at roughly 3.7% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Medical Care Facilities · Pick stocks to compare with M12.XETR

CompareIntrinsic value
EUZ.XETREckert & Ziegler SE
€14.00+4.56%74
MAK.XETRMaternus-Kliniken Aktiengesellschaft
€0.86-2.84%61
V3V.XETRFamiCord AG
€2.68-3.94%39
AJ91.XETRDocCheck AG
€10.50+0.00%57
7V0.XETRDarwin AG
€6.30-3.08%24
LIK.XETRLimes Schlosskliniken AG
€530.00+1.92%67
FYB.XETRFormycon AG
€18.68-1.68%10
DMP.XETRDermapharm Holding SE
€38.90+1.17%49

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing M12.XETR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.